Nuclear transport of galectin-3 and its therapeutic implications
about
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor MicroenvironmentsGalectins in epithelial functionsGalectin-3 in angiogenesis and metastasis.Serum galectin-3 as a potential marker for gastric cancer.Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.Galectin-3 inhibitors: a patent review (2008-present).Galectin-3 in autoimmunity and autoimmune diseases.Combining Unique Multiplex Gateway Cloning and Bimolecular Fluorescence Complementation (BiFC) for High-Throughput Screening of Protein-Protein Interactions.Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMRHow microgravity changes galectin-3 in thyroid follicles.Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine KinaseTissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersGalectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics.The emerging role of galectins in high-fatality cancers.Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination
P2860
Q26744513-6EE2BFF8-A62D-47A1-A6F0-C6BD68425AADQ27000800-925045C2-8F5D-4193-94A8-42C9EA48EBAFQ27687444-9BF3A81D-A5F3-4470-A401-B30EC68FE5A3Q35207994-5333C306-AD78-4CCF-9EF2-E44F5D86D2DDQ36642752-A43BC405-49AE-41D0-9D6F-FEBF0BEBFDD7Q38238525-9C346EC0-8A2C-4CE3-B16A-A5FA1F700EF5Q38542678-AFA87ADF-5E6C-4B22-8CAB-837E1FBB95B4Q39562001-59238531-1762-469E-821B-29D427FE12CBQ41058851-3E577CDD-5F00-40A4-B68E-12EAAC86348AQ41906428-25E40217-035C-4183-9439-89ECD04EC021Q42223040-8C1A5A39-AD3E-454C-BDD8-09F6B20BFFC1Q42378844-9223613E-F8B7-4EA8-9843-9D53119BEDE2Q47653100-B0485E9B-33CF-4E7F-A862-D547FD260475Q48159180-58D43241-7557-4AE9-BF77-5311620E6C2EQ49670112-71630595-8111-430B-B045-8087802CB7F7Q50101341-717AFFF4-09D5-40E2-B7C5-8F03DC0FE1F5Q52340243-91B0D498-99A2-42EC-A259-A76B939BCF51Q57157917-4BFF3406-5A57-4B94-909C-F5C2377F7E3E
P2860
Nuclear transport of galectin-3 and its therapeutic implications
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nuclear transport of galectin-3 and its therapeutic implications
@ast
Nuclear transport of galectin-3 and its therapeutic implications
@en
Nuclear transport of galectin-3 and its therapeutic implications
@nl
type
label
Nuclear transport of galectin-3 and its therapeutic implications
@ast
Nuclear transport of galectin-3 and its therapeutic implications
@en
Nuclear transport of galectin-3 and its therapeutic implications
@nl
prefLabel
Nuclear transport of galectin-3 and its therapeutic implications
@ast
Nuclear transport of galectin-3 and its therapeutic implications
@en
Nuclear transport of galectin-3 and its therapeutic implications
@nl
P2860
P3181
P1476
Nuclear transport of galectin-3 and its therapeutic implications
@en
P2093
Avraham Raz
Tatsuyoshi Funasaka
P2860
P3181
P356
10.1016/J.SEMCANCER.2014.03.004
P407
P577
2014-03-19T00:00:00Z